FDA peptide production rules decision coming

The FDA is poised to make a decision this week on loosening regulations around peptide production, potentially opening the market to new players. Telehealth companies are already positioning themselves to capitalize on this regulatory shift, anticipating significant financial opportunities in the peptide space.